The frequency of CD4+Foxp3+ Treg cells in peripheral blood is negatively correlated with severity of graft versus host diseases in humans (26) and is also regarded as a biomarker for hematopoietic cell transplantation outcomes (27). This evidence concerns the gene FOXP3 and glycogen storage disease VI.